Editas-Logo-Small (1).jpg
Editas Medicine to Host Conference Call Discussing First Quarter 2016 Corporate Update and Results
May 09, 2016 08:00 ET | Editas Medicine, Inc.
CAMBRIDGE, Mass., May 09, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Monday,...
Editas-Logo-Small (1).jpg
Editas Medicine Achieves Milestone under its Collaboration with Juno Therapeutics
May 04, 2016 07:30 ET | Editas Medicine, Inc.
CAMBRIDGE, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, announced today that it has achieved a $2.5 million milestone under its...
Editas-Logo-Small (1).jpg
Editas Medicine Announces Presentations at Upcoming Scientific Conferences
April 27, 2016 16:01 ET | Editas Medicine, Inc.
CAMBRIDGE, Mass., April 27, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that Editas scientists will present data from its...
Editas-Logo-Small (1).jpg
Editas Medicine to Present at Deutsche Bank 41st Annual Health Care Conference
April 27, 2016 08:00 ET | Editas Medicine, Inc.
CAMBRIDGE, Mass., April 27, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present a company overview at the Deutsche...
Editas-Logo-Small (1).jpg
Editas Medicine to Present at 15th Annual Needham Healthcare Conference
April 06, 2016 16:01 ET | Editas Medicine, Inc.
CAMBRIDGE, Mass., April 06, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present a company overview at the 15th...
Editas-Logo-Small (1).jpg
Editas Medicine Reports Fourth Quarter and Full Year 2015 Financial Results
March 30, 2016 08:00 ET | Editas Medicine, Inc.
Well-positioned to advance multiple programs and continue expansion of genome editing platform Cash balance of approximately $230 million funds diversified pipeline Executive team and board of...